January 18, 2018
6 Duke Companies Featured at CED Life Science Conference
The Council for Entrepreneurial Development (CED) has selected 70 companies, 6 of which are Duke spin-outs, to be featured at the 27th annual CED Life Science Conference 2018, held February 27-28 in Raleigh, NC.
The featured companies were chosen through a selection committee from the local community, to include angel investors, venture capital firms, community and corporate partners, and CED’s Director of Entrepreneurship Jay Bigelow.
The selected Duke companies are:
- Lumedica, founded by Dr. Adam Wax, developed a new low-cost optical coherence tomography (OCT) scanner that could dramatically extend the impact of the imaging technology for eye health by making eye imaging more affordable, accessible and easier to use.
- EydisBio is a therapeutics company developing small molecule drug conjugates capable of delivering a range of cargoes for either diagnosis or treatment.
- Celldom is developing next-generation single cell omics for new drug R&D, companion diagnostics, and personalized medicine.
- Element Genomics is developing a high-throughput platform for understanding gene regulatory elements in order to identify new drug targets for common diseases.
- Cellecive BioTherapy is an early-stage biotech spinout with a proprietary pipeline and technology platform focused on unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses.
- MVTRAK is a health and safety monitoring company solving the $20B problem in concussion and Traumatic Brain Injury (TBI) for sports, the military, and the elderly.
Running parallel to the CED Conference, the Wallace H. Coulter Foundation and Duke University will host the 2018 Coulter Investment Forum spotlighting life science companies from a dozen top-tier universities across the U.S.
Element Genomics has been chosen to present at this event as well.Learn More